The Asia Pacific oligonucleotide synthesis market is expected to reach US$ 872.98 Mn in 2027 from US$ 334.26 Mn in 2018 the market is estimated to grow with a CAGR of 14.7% from 2019-2027.
The growth of the Oligonucleotide Synthesis market is driven by the factors such as, the growing use of synthesized oligonucleotides and government support for biotechnology research in Asia Pacific. However, the market is likely to slower down its growth due to dearth of skilled professional in the region.
The high growth of the market is anticipated on account of the rise in the investment are enabling technological developments and standard biological parts. For Instance, The Biotechnology Industry Research Assistance Council (BIRAC) is a public entity developed by the DBT, government of India, which aims to strengthen and empower the emerging biotech enterprises. DBT along with the BIRAC plays important role in transforming the biotech sector by Make in India and Startup India and the aim is to inform the India Bioeconomy to US$ 100 billion by the 2025. Developments such as partnerships and increasing focus on synthetic biology research is expected to contribute to the growth of the market.
Japan is expected to lead the market in the Asia Pacific region owing to the rising prevalence of chronic diseases such as coronary diseases & cancer and increase in awareness regarding cancer in the country. Moreover the government initiative for research activities, collaboration among major player in country. Therefore, considering the above mentioned factors the growth of the market in the country is likely to contribute largest share in the Asia Pacific region during the forecast period.
Rest of Asia Pacific Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)
- This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.
- This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.
ASIA PACIFIC OLIGONUCLEOTIDE SYNTHESIS – MARKET SEGMENTATION
By Product
- Synthesized Oligonucleotides
- Primers
- Probes
- Large-Scale Synthesis
- Others
- Reagents
- Equipment
By Application
- Research
- Diagnostics
- Therapeutics
By End User
- Academic Research Institutes
- Pharmaceutical & Biotechnology Companies
- Diagnostic Laboratories
- Other End Users
By Geography
Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
Company Profiles
- Molecular Assemblies
- Twist Bioscience
- Evonetix
- Nuclera Nucleics Ltd
- Camena Bio
- DNA Script
- Iridia, Inc.,
- Helixworks
- Ansa Biotechnologies, Inc.,
- Synthomics, Inc.,
Asia Pacific Oligonucleotide Synthesis Report Scope
Report Attribute | Details |
---|---|
Market size in 2018 | US$ 334.26 Million |
Market Size by 2027 | US$ 872.98 Million |
Global CAGR (2019 - 2027) | 14.7% |
Historical Data | 2016-2017 |
Forecast period | 2019-2027 |
Segments Covered |
By Product
|
Regions and Countries Covered | Asia-Pacific
|
Market leaders and key company profiles |
- Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
- PEST and SWOT Analysis
- Market Size Value / Volume - Global, Regional, Country
- Industry and Competitive Landscape
- Excel Dataset



Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Product, Application, End User, and Country

Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Australia, China, Japan, South Korea
Trends and growth analysis reports related to Life Sciences : READ MORE..
The List of Companies
- Molecular Assemblies
- Twist Bioscience
- Evonetix
- Nuclera Nucleics Ltd
- Camena Bio
- DNA Script
- Iridia, Inc.,
- Helixworks
- Ansa Biotechnologies, Inc.,
- Synthomics, Inc.,